المؤلفون: Ministry of Health, Malawi, Boston University, Michigan State University

المصدر: The Impact, Feasibility Acceptability and Cost Effectiveness of the RTS,S/AS01 Malaria Vaccine in School Aged Children

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06424002Test

المؤلفون: Malaria Research and Training Center, Bamako, Mali, London School of Hygiene and Tropical Medicine

المصدر: A Phase 1/2a Single Centre, Randomised, Placebo-controlled, Double-blind, Dose-escalation, Age De-escalation, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Malaria-exposed Malian Adults and Children

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06413108Test

المصدر: Seasonal Malaria Chemoprevention Rapid Assessment Study Mozambique

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06337253Test

المؤلفون: Bill and Melinda Gates Foundation, University Hospitals Bristol and Weston NHS Foundation Trust

المصدر: A Phase 1 Study to Assess the Safety and Immunogenicity of R21/Matrix-M™ Administered in an Escalating Dose, Multi-prime Vaccination Schedule in Healthy Adults

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06320535Test

المساهمون: Meta Roestenberg, Prof

المصدر: Durability of Protection After Single Immunisation With Genetically Attenuated Plasmodium Falciparum ∆mei2 (GA2) Sporozoites - a Follow-up, Controlled Human Malaria Rechallenge Study

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06293339Test

المؤلفون: Medicines for Malaria Venture

المصدر: A Phase 1, Randomised, Double Blind Placebo-controlled, First Time in Human Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Oral Doses and Food Effect of GSK4024484 in Healthy Adult Participants.

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06171113Test

المصدر: Phase I Clinical Trial to Assess the Safety and Immunogenicity of the Malaria Vaccine Candidate RH5.1 Soluble Protein in Matrix-MTM Using Two Dosing Regimens

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06141057Test

المؤلفون: Kamuzu University of Health Sciences

المصدر: Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06083688Test

المؤلفون: Cipto Mangunkusumo Hospital, PT Natura Nuswantara Nirmala

المساهمون: Syamsudin Abdillah,Ph.D, Pharm D, Profesor Dr Syamsudin Abdillah, M.Biomed

المصدر: Abdlah S, Tambunan RM, Saga YM, Fara Y. Ethno-botanal survey of plants used the tradnal treatment of malar SeKepayang, Asahan of North Sumatera. Asn Pac J Trop Med. 2014 Sep;7S1:S104-7. do 10.1016/S1995-7645(14)60213-3.
J S, Shen M, Zhang F, X J. Recent Advances Momorda charant: Functnal Components and Blogal Acts. t J Mol Sc 2017 Nov 28;18(12):2555. do 10.3390/ms18122555.
Chen F, Huang G, Yang Z, Hou Y. Antxant acty of Momorda charant polysacchare and s derates. t J Bl Macromol. 2019 Oct 1;138:673-680. do 10.1016/j.bmac.2019.07.129. Epub 2019 Jul 22.
Wang S, L Q, Zeng T, Zhan J, Zhao H, Ho CT, Xo Y, LS. munomodulatory effects and assocted mechanms of Momorda charant and s phytochemals. Food Funct. 2022 Nov 28;13(23):11986-11998. do 10.1039/d2fo02096c.
Nelwan EJ, Ekawati LL, Tjahjono B, Setiabudy R, Sutanto I, Chand K, Ekasari T, Djoko D, Basri H, Taylor WR, Duparc S, Subekti D, Elyazar I, Noviyanti R, Sudoyo H, Baird JK. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia. BMC Med. 2015 Dec 11;13:294. doi: 10.1186/s12916-015-0535-9.
Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06036030Test

المؤلفون: Kamuzu University of Health Sciences, Doris Duke Charitable Foundation

المساهمون: Lauren Cohee, Assistant Professor of Pediatrics

المصدر: Cohee LM, Val C, Coalson JE, Nyambalo A, Chombe M, Ngwa A, BaulenA, Seydel KB, Wson ML, Taylor TE, Mathanga DP, Laufer MK. School-based screeng and treatment may reduce P. falcarum transmsn. ScRep. 2021 Mar 25;11(1):6905. do 10.1038/s41598-021-86450-5.
Cohee LM, Opondo C, Clarke SE, Hallay KE, Cano J, Shper AG, Barger-Kamate B, Djde A, Drra S, Dokras A, Kamya MR, Lutumba P, Ly AB, Nankabwa J NjagJK, Maa H, MaekSebuguzC, Matanga J, Okello G, Rohner F, Roschn N, RouhanS, Ssoko MS, Staedke SG, Thera MA, Turner EL, Van Geertruyden JP, Zmerman MB, Jukes MCH, Brooker SJ, Allen E, Laufer MK, Cho RM. Prevente malar treatment among school-aged chdren sub-Saharan Afra: a systemat revw and meta-analyses. Lancet Glob Health. 2020 Dec;8(12):e1499-e1511. do 10.1016/S2214-109X(20)30325-9. Epub 2020 Oct 22.
Clinical Trial to Evaluate Intermittent Screening and Treatment and Intermittent Preventive Treatment of Malaria in Asymptomatic Schoolchildren to Decrease P. Falciparum Infection and Transmission: Phase 2 Comparing Drug Regimens

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05980156Test